128 related articles for article (PubMed ID: 36178187)
21. A Potential Biomarker for Predicting the Risk of Radiation-Induced Fibrosis in the Lung.
Groves AM; Williams JP; Hernady E; Reed C; Fenton B; Love T; Finkelstein JN; Johnston CJ
Radiat Res; 2018 Nov; 190(5):513-525. PubMed ID: 30117783
[TBL] [Abstract][Full Text] [Related]
22. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
[TBL] [Abstract][Full Text] [Related]
23. The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Samukawa T; Hamada T; Uto H; Yanagi M; Tsukuya G; Nosaki T; Maeda M; Hirano T; Tsubouchi H; Inoue H
BMC Pulm Med; 2012 Sep; 12():55. PubMed ID: 22963039
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
Antonadou D
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
[TBL] [Abstract][Full Text] [Related]
25. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
Chen F; Shu XM; Wang DX; Xie Y; Wang GC
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
[TBL] [Abstract][Full Text] [Related]
27. Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis.
Wennberg B; Gagliardi G; Sundbom L; Svane G; Lind P
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1196-206. PubMed ID: 11955730
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and Characteristics of Pneumonitis Following Irradiation of Breast Cancer.
Werner EM; Eggert MC; Bohnet S; Rades D
Anticancer Res; 2019 Nov; 39(11):6355-6358. PubMed ID: 31704867
[TBL] [Abstract][Full Text] [Related]
29. Differential levels of surfactant protein A, surfactant protein D, and progesterone to estradiol ratio in maternal serum before and after the onset of severe early-onset preeclampsia.
Kale K; Vishwekar P; Balsarkar G; Jassawalla MJ; Sawant G; Madan T
Am J Reprod Immunol; 2020 Feb; 83(2):e13208. PubMed ID: 31702086
[TBL] [Abstract][Full Text] [Related]
30. The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study.
Alay H; Laloglu E
J Med Virol; 2021 Oct; 93(10):6008-6015. PubMed ID: 34232533
[TBL] [Abstract][Full Text] [Related]
31. What do changes in concentrations of serum surfactant proteins A and D in OSA mean?
Liang S; Li N; Heizhati M; Yao X; Abdireim A; Wang Y; Abulikemu Z; Zhang D; Chang G; Kong J; Zhou L; Hong J; Ying T; Zhang Y
Sleep Breath; 2015 Sep; 19(3):955-62. PubMed ID: 25619705
[TBL] [Abstract][Full Text] [Related]
32. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Willner J; Jost A; Baier K; Flentje M
Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
[TBL] [Abstract][Full Text] [Related]
33. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
34. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia.
Daimon T; Tajima S; Oshikawa K; Bando M; Ohno S; Sugiyama Y
Intern Med; 2005 Aug; 44(8):811-7. PubMed ID: 16157978
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study.
Vasiljevic D; Arnold C; Neuman D; Fink K; Popovscaia M; Kvitsaridze I; Nevinny-Stickel M; Glatzer M; Lukas P; Seppi T
Strahlenther Onkol; 2018 Jun; 194(6):520-532. PubMed ID: 29450591
[TBL] [Abstract][Full Text] [Related]
36. The Efficacy and Safety of Acupuncture for Preventing Radiation Pneumonitis in Patients With Lung Cancer: A Prospective, Single-Blinded, Randomized Pilot Proof-of-Principle Study.
Kong M; Lee SH; Kim J; Lee BJ; Kim KI
Integr Cancer Ther; 2020; 19():1534735420908327. PubMed ID: 32100576
[No Abstract] [Full Text] [Related]
37. Serum heat shock protein 47 levels in patients with drug-induced lung disease.
Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Matsuoka Y; Kubota H; Mine M; Mukae H; Nagata K; Kohno S
Respir Res; 2013 Nov; 14(1):133. PubMed ID: 24256690
[TBL] [Abstract][Full Text] [Related]
38. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
[TBL] [Abstract][Full Text] [Related]
39. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
[TBL] [Abstract][Full Text] [Related]
40. Effect of breast cancer adjuvant therapies on potential biomarkers of pulmonary inflammation.
Piperis M; Provatopoulou X; Sagkriotis A; Kalogera E; Ampatzoglou E; Zografos GC; Athanasiou E; Gounaris A
Anticancer Res; 2012 Nov; 32(11):4993-5002. PubMed ID: 23155270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
